St. Jude Clinical Trials
-
COVID-19 Pediatric Vaccine Studies
St. Jude is planning to participate in clinical trials to test COVID-19 prevention vaccines in healthy children. Find out more.
SENDAI: A Phase I Study of Unmodified Live Intranasal Sendai Virus Vaccine in Children and Toddlers: Assessment of Safety and Immunogenicity
Eligibility:
- Child is greater than or equal to twelve (12) months and less than twenty-four (24) months.
- Child has adequate blood, liver and kidney function.
- Child has no history of lung disease, asthma, and hospitalization for respiratory illness, immunodeficiency, sickle cell disease, or any other serious underlying condition.
Collaborative Clinical Trials
IMPAACT2036: Study of long-acting injectable treatment for HIV
Diseases Treated:
Eligibility:
- 2–11 years old
- Body weight greater than 10 kg but less than 40 kg
- Confirmed HIV infection
- Receiving antiretroviral therapy (ART) using 2 or more drugs from 2 or more antiretroviral drug classes for at least 6 months
- Has not switched ART regimens due to treatment failure
SENDAI: A Phase I Study of Unmodified Live Intranasal Sendai Virus Vaccine in Children and Toddlers: Assessment of Safety and Immunogenicity
Eligibility:
- Child is greater than or equal to twelve (12) months and less than twenty-four (24) months.
- Child has adequate blood, liver and kidney function.
- Child has no history of lung disease, asthma, and hospitalization for respiratory illness, immunodeficiency, sickle cell disease, or any other serious underlying condition.